We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Technologies Help Clinicians Identify Head Trauma and Stroke

By MedImaging International staff writers
Posted on 05 Apr 2017
Print article
Image: The MedyMatch intracranial bleed detection application, including 3D rendering of the location and volume of bleeding (Photo courtesy of MedyMatch).
Image: The MedyMatch intracranial bleed detection application, including 3D rendering of the location and volume of bleeding (Photo courtesy of MedyMatch).
A healthcare IT technology company has agreed to license an innovative 3D system for identifying intracranial bleeding following head trauma, to a large healthcare cloud computing collaborative.

The Artificial Intelligence (A.I.)-based clinical decision support application is intended to help imaging experts in acute care settings, such as hospital emergency rooms, detect bleeding in the brain.

The agreement was signed between MedyMatch, and the IBM Watson Health collaborative. In the next phase the companies plan to develop interoperability capabilities between the MedyMatch application and IBM Watson Health Imaging products. MedyMatch Technology solutions make use of advanced cognitive analytics, and A.I. to provide real-time decision support tools for acute care settings.

The MedyMatch intracranial bleed assessment application is currently undergoing a clinical trial, with the aim to achieve US Food and Drug Administration (FDA) Class III Premarket Approval (PMA).

Chairman and CEO of MedyMatch, Gene Saragnese, said, "The opportunity to license our deep vision application to IBM Watson Health creates a unique value proposition in healthcare. Engaging closely with IBM allows for a near-zero footprint implementation at a customer location delivering 'A.I. to the bedside' where I believe the future of healthcare lies. At MedyMatch, we believe improvements in the interpretation of data will lead to better decisions, better decisions will lead to better outcomes for patients and lower cost for healthcare. This is what drives us forward every day."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
New
Ultrasound System
Acclarix AX9
New
Oncology Information System
RayCare

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.